WallStreetZenWallStreetZen

NASDAQ: FBLG
Fibrobiologics Inc Stock

$13.00-0.06 (-0.46%)
Updated Mar 1, 2024
FBLG Price
$13.00
Fair Value Price
N/A
Market Cap
$424.25M
52 Week Low
$6.53
52 Week High
$55.00
P/E
-19.12x
P/B
338.58x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$16.49M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
8.43
Operating Cash Flow
-$6M
Beta
-18.22
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FBLG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FBLG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FBLG is poor value based on its book value relative to its share price (338.58x), compared to the US Biotechnology industry average (6.18x)
P/B vs Industry Valuation
FBLG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more FBLG due diligence checks available for Premium users.

Be the first to know about important FBLG news, forecast changes, insider trades & much more!

FBLG News

Valuation

FBLG price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-19.12x
Industry
15.19x
Market
36.17x

FBLG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
338.58x
Industry
6.18x
FBLG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FBLG's financial health

Profit margin

Revenue
$0.0
Net Income
-$9.7M
Profit Margin
0%
FBLG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$11.8M
Liabilities
$10.6M
Debt to equity
8.43
FBLG's short-term assets ($9.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FBLG's short-term assets ($9.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FBLG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.6M
Investing
-$2.0k
Financing
$0.0
FBLG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FBLG vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FBLG$424.25M-0.46%-19.12x338.58x
PRAX$424.56M+5.90%-1.48x4.89x
CELC$421.86M+12.02%-6.38x4.54x
PGEN$420.67M+9.74%-4.57x2.85x
EPIX$418.94M-0.32%-16.05x2.98x

Fibrobiologics Stock FAQ

What is Fibrobiologics's quote symbol?

(NASDAQ: FBLG) Fibrobiologics trades on the NASDAQ under the ticker symbol FBLG. Fibrobiologics stock quotes can also be displayed as NASDAQ: FBLG.

If you're new to stock investing, here's how to buy Fibrobiologics stock.

What is the 52 week high and low for Fibrobiologics (NASDAQ: FBLG)?

(NASDAQ: FBLG) Fibrobiologics's 52-week high was $55.00, and its 52-week low was $6.53. It is currently -76.36% from its 52-week high and 99.08% from its 52-week low.

How much is Fibrobiologics's stock price per share?

(NASDAQ: FBLG) Fibrobiologics stock price per share is $13.00 today (as of Mar 1, 2024).

What is Fibrobiologics's Market Cap?

(NASDAQ: FBLG) Fibrobiologics's market cap is $424.25M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Fibrobiologics's market cap is calculated by multiplying FBLG's current stock price of $13.00 by FBLG's total outstanding shares of 32,634,366.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.